Peer-reviewed veterinary case report
How vets use joint injections without steroids for dogs
By Sepulveda, Camila P et al.·Published in Frontiers in veterinary science·2026·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A survey of the clinical usage of intra-articular therapeutics in dogs by veterinary practitioners with a focus on non-steroidal therapies.
- Species:
- dog
Plain-English summary
A survey of veterinarians revealed that many are using non-steroidal intra-articular therapies, like platelet-rich plasma (PRP) and viscosupplements, to help dogs with osteoarthritis (OA), a painful joint condition. The elbow joint was the most commonly treated area, and many vets reported seeing significant improvement in their patients after these treatments. Most practitioners preferred using PRP and viscosupplements based on scientific evidence of their safety and effectiveness. Overall, the findings suggest that these therapies can be beneficial for dogs suffering from chronic joint pain.
People also search for: dog osteoarthritis treatment · PRP therapy for dogs · viscosupplements for dog joints
Abstract
Osteoarthritis (OA) is a degenerative condition of the joint, whose progressive characteristics can lead to significant functional impairment and pain in the canine patient. Interest has increased regarding the use of intra-articular (IA) therapeutics as part of the multimodal management of canine OA. This study aimed to present the clinical experience of surgery and rehabilitation practitioners using these therapeutics to better understand their clinical usage, perceived outcomes, and clinical reasoning for product usage. A survey inquiring about IA injections with a focus on non-steroidal intra-articular therapeutics (NSIATs), including platelet-rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solution (APS), cellular therapy, viscosupplements, and radionuclide, was distributed to canine practitioners. A total of 174 surveys were included in the results. Intra-articular injections were performed by 164 participants. Among these, 144 practitioners used NSIATs. The most common joint injected with steroidal and/or NSIATs was the elbow. The top reason for participants' decision as to which NSIATs they preferentially used was scientific data and articles published regarding the product's safety and efficacy. The most used NSIATs were PRP and viscosupplements, followed by cellular therapy, radionuclides, ACS, and APS. Practitioners reported that the most common reason to use NSIATs, except for APS, was chronic articular pathology needing 'maintenance' or routine injections. Pertaining to the top two most commonly used products, most participants did not combine PRP with other IA therapeutics. In the case of viscosupplements, 40% of the practitioners combined them with corticosteroids. According to the participants' subjective assessment, most of the positive responders presented substantial or some clinical improvement after PRP or viscosupplements administration. As the first survey on this topic of small animal studies, these results provide valuable insights into the use of NSIATs in canines.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41756585/